Skip to main content

Cefpodoxime (International)

Note: In some countries, this medicine may only be approved for veterinary use.

In the US, Cefpodoxime (cefpodoxime systemic) is a member of the drug class third generation cephalosporins and is used to treat Bladder Infection, Bronchitis, Gonococcal Infection - Disseminated, Gonococcal Infection - Uncomplicated, Kidney Infections, Middle Ear Infections, Pneumonia, Sinusitis, Skin or Soft Tissue Infection, Tonsillitis/Pharyngitis and Upper Respiratory Tract Infection.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J01DD13

CAS registry number (Chemical Abstracts Service)

0080210-62-4

Chemical Formula

C15-H17-N5-O6-S2

Molecular Weight

427

Therapeutic Category

Antibacterial: Cephalosporin

Chemical Name

(+)-(6R,7R)-7-[2-(2-amino-4-tiazolyl)glyoxylamido]-3-(metoxymetyl)-8-oxo-5-tia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7²-(Z)-(O-metlyloxime)

Foreign Names

Generic Names

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
BANMBritish Approved Name (Modified)
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Further information on drug naming conventions: International Nonproprietary Names.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Search international drugs